Clinical Trial Update: Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing nepafenac to ketorolac eye drops for prevention of intraoperative miosis in cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Nepafenac (nepafenac)
• ketorolac eye drops (ketorolac)

Snippet

Sponsor: Assiut University | Conditions: Cataract, Miosis | Phase 2 | Status: UNKNOWN